Syncona Portfolio Ltd
- SEC CIK
- 0001725042
- Latest filing
- Aug 6, 2026
Holdings in Q4 2021
Holdings as of Dec 31, 2021, filed Feb 11, 2022. Long positions only.
- Positions
- 4
- No filing for Q3 2021
- Portfolio value
- $104.7M
- No filing for Q3 2021
Syncona Portfolio Ltd did not file a 13F for Q3 2021, so these holdings cannot be compared with the previous quarter and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 11,086,909 | $55.5M | 53.1% | – | – | – |
| AUTLAutolus Therapeutics plc | SPON ADS | 7,346,829 | $38.1M | 36.4% | – | – | History |
| Freeline Therapeutics Hldgs35655L107 | SPONSORED ADS | 2,950,000 | $5.84M | 5.6% | – | – | – |
| ADAPYAdaptimmune Therapeutics PLC | SPONDS ADR | 1,377,294 | $5.17M | 4.9% | – | – | History |